Success Story: Breaking Barriers in Cancer Immunology: NIW Approval for a Vietnamese Researcher

Client’s Testimonial:

 

"Timely response and very supportive during the excruciatingly long EB2/NIW process. Really appreciate the realistic expectations set from the get-go and personalized legal advice for my unique situation.”

 


 

March 5th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for an MD/PhD Candidate in the Field of Cancer Immunology (Approval Notice).

 


 

General Field: Cancer Immunology

 

Position at the Time of Case Filing: MD/PhD Candidate

 

Country of Origin: Vietnam

 

State of Residence at the Time of Filing: Pennsylvania

 

Approval Notice Date: March 5th, 2026

 

Processing Time: 18 months, 5 days (Premium Processing Upgrade Requested)

 


 

Case Summary:

 

While many NIW petitions are filed for Ph.D. holders, this success story highlights a talented researcher who holds a B.A. in Biology - Cell and Biochemistry. Her unprecedented impact on the field of cancer immunology proves that extraordinary capability and national importance are not strictly bound by doctoral degrees.

 

Targeting the Immune Microenvironment of Uveal Melanoma

 

The petitioner, a highly accomplished expert in cancer immunology, focuses her proposed endeavor on characterizing the immune microenvironment of uveal melanoma.  Her critical research seeks to identify key mechanisms of immunosuppression and drug resistance, translating these discoveries into novel targets for life-saving immunotherapies.

 

The profound national importance of her work is undeniable. Because her research directly addresses severe public health challenges in cancer treatment, her projects have been heavily supported with funding from some of the nation's most prestigious organizations. These include the National Institutes of Health (NIH), the National Cancer Institute (NCI), the National Heart, Lung, and Blood Institute (NHLBI), and the National Eye Institute (NEI).

 

A Record of Scholarly Impact

 

To satisfy the rigorous Dhanasar framework, North America Immigration Law Group (Chen Immigration Law Associates) strategically showcased the sheer magnitude of the client's scientific contributions. Despite being early in her career trajectory, she has already documented the results of her work in 13 peer-reviewed journal articles, 1 accepted first-authored journal article, and 11 abstracts.

 

Furthermore, the global scientific community's reliance on her methodologies is staggering. Her publications have been cited a total of 2,453 times by independent researchers around the world. This exceptionally high citation count—placing several of her papers in the top 0.1% and top 1% of the field of Immunology—unequivocally establishes her as a leading voice in cancer research.

 

By meticulously detailing her publication record, citation metrics, and vital federal funding, we successfully demonstrated that waiving the labor certification requirement was in the undeniable interest of the United States.